Last reviewed · How we verify
Alpheprol (ALPRENOLOL)
Alpheprol (generic name: ALPRENOLOL) is a alprenolol drug. It is currently FDA-approved.
At a glance
| Generic name | ALPRENOLOL |
|---|---|
| Drug class | alprenolol |
| Target | 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, Beta-1 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Alpheprol CI brief — competitive landscape report
- Alpheprol updates RSS · CI watch RSS
Frequently asked questions about Alpheprol
What is Alpheprol?
Alpheprol (ALPRENOLOL) is a alprenolol drug.
What is the generic name of Alpheprol?
ALPRENOLOL is the generic (nonproprietary) name of Alpheprol.
What drug class is Alpheprol in?
Alpheprol belongs to the alprenolol class. See all alprenolol drugs at /class/alprenolol.
What development phase is Alpheprol in?
Alpheprol is FDA-approved (marketed).
What does Alpheprol target?
Alpheprol targets 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, Beta-1 adrenergic receptor and is a alprenolol.
Related
- Drug class: All alprenolol drugs
- Target: All drugs targeting 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, Beta-1 adrenergic receptor
- Therapeutic area: All drugs in Cardiovascular
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing